�鶹ֱ��

Partner George E. Quillin was quoted in Law360’s first half recap of the key patent rulings and decisions in 2021, “,” highlighting the importance of the high court’s ruling on the Patent Trial and Appeal Board process.

On the significance of U.S. vs. Arthrex decision, George said, “The court’s remedy requires only that the director have the discretion to decide whether or not he will rehear any of the IPRs. The cynic can imagine a busy bureaucrat’s easy choice on such a decision.”